erm

macrolide-lincosamide-streptogramin B resistance

Macrolide-lincosamide-streptogramin B resistance refers to cross-resistance against these three antibiotic classes, often mediated by 23S rRNA methylase genes. Companies must integrate this into biological risk matrices, ensuring compliance with ISO 31000 risk management principles and local health regulations.

Curated by Winners Consulting Services Co., Ltd.

Putting this into practice

Winners Consulting helps organizations turn this concept into workable policies, processes and audit readiness.

Need help with compliance implementation?

Request Free Assessment